AUB
NTLA icon

Atlantic Union Bankshares’s Intellia Therapeutics NTLA Stock Holding History

Atlantic Union Bankshares’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26 Hold
2
– – ﹤0.01% 1724
2025
Q4 		$18 Hold
2
– – ﹤0.01% 1676
2025
Q3 		$35 Hold
2
– – ﹤0.01% 1626
2025
Q2 		$19 Buy
+2
New +$16 ﹤0.01% 1218

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Atlantic Union Bankshares's NTLA Position: Q1 2026 in Review

Atlantic Union Bankshares held its Intellia Therapeutics (NTLA) position steady in Q1 2026 at 2 shares worth $26. The position accounts for ﹤0.01% of the portfolio, ranked #1724.

Atlantic Union Bankshares first reported a position in NTLA in Q2 2025 and has held it in 4 quarters since. The position peaked at $35 in Q3 2025. 302 funds tracked by Wall St. Rank hold NTLA as of Q1 2026.

  • Atlantic Union Bankshares held 2 shares of Intellia Therapeutics worth $26 as of Q1 2026.
  • Atlantic Union Bankshares left its Intellia Therapeutics share count unchanged in Q1 2026.
  • Intellia Therapeutics made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q1 2026, its #1724 holding.
  • Atlantic Union Bankshares first reported a position in Intellia Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Atlantic Union Bankshares's Intellia Therapeutics position peaked at $35 in Q3 2025.
  • 302 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.